Through the 90-day period concluding February 19, 2026, Ani Pharmaceuticals's top three insider stakeholders include TenPercentOwner Venture Partners Ii Lp Meridian (1.82Mn shares), Head Of R&D And Coo Novitium Ops Muthusamy Shanmugam (574.85K shares), President & Ceo Nikhil Lalwani (358.57K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Venture Partners Ii Lp Meridian | 1,819,259 | 16 Aug, 2023 | |
| Muthusamy Shanmugam | Head Of R&D And Coo Novitium Ops | 574,848 | 13 Feb, 2026 |
| Nikhil Lalwani | President & Ceo | 358,574 | 17 Feb, 2026 |
| Chad Gassert | Svp Corp. Dev. & Strategy | 224,605 | 17 Feb, 2026 |
| Stephen P. Carey | Svp & Cfo | 170,083 | 17 Feb, 2026 |
| James G. Marken | Svp Ops & Prod Dev | 117,829 | 11 Jun, 2024 |
| Christopher Mutz | Head Of Rare Disease | 90,163 | 17 Feb, 2026 |
| Ori Gutwerg | Svp And Generics | 76,094 | 17 Feb, 2026 |
| Meredith Cook | Sr. Vp And General Counsel & Sec. | 67,550 | 17 Feb, 2026 |
| Patrick D Walsh | 58,405 | 17 Nov, 2025 | |
| Krista Davis | Svp And Chief Hr Officer | 53,077 | 17 Feb, 2026 |
| Robert E. Jr Brown | 49,021 | 29 Apr, 2022 | |
| David Nash | 38,561 | 24 May, 2023 | |
| Thomas Andrew Rowland | Svp And Head Established Brands | 38,109 | 17 Feb, 2026 |
| Thomas Haughey | 36,521 | 14 Aug, 2025 | |
| Renee P Tannenbaum | 25,157 | 09 Dec, 2025 | |
| Jeanne Thoma | 23,405 | 20 Aug, 2025 | |
| Antonio R Pera | 22,660 | 04 Sep, 2025 | |
| Matthew J Leonard | 6,864 | 26 Aug, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 14 Feb, 2026 | Thomas Andrew Rowland | Common Stock | D | 485 | $77.36 | 38,109 | D | F |
| 14 Feb, 2026 | Stephen P. Carey | Common Stock | D | 2,448 | $77.36 | 170,083 | D | F |
| 14 Feb, 2026 | Nikhil Lalwani | Common Stock | D | 10,298 | $77.36 | 358,574 | D | F |
| 14 Feb, 2026 | Ori Gutwerg | Common Stock | D | 1,888 | $77.36 | 76,094 | D | F |
| 14 Feb, 2026 | Christopher Mutz | Common Stock | D | 2,403 | $77.36 | 90,163 | D | F |
| 14 Feb, 2026 | Chad Gassert | Common Stock | D | 1,717 | $77.36 | 66,021 | D | F |
| 14 Feb, 2026 | Meredith Cook | Common Stock | D | 1,779 | $77.36 | 67,550 | D | F |
| 14 Feb, 2026 | Krista Davis | Common Stock | D | 1,290 | $77.36 | 53,077 | D | F |
| 13 Feb, 2026 | Meredith Cook | Common Stock | D | 500 | $76.80 | 69,329 | D | S |
| 12 Feb, 2026 | Thomas Andrew Rowland | Common Stock | D | 566 | $76.70 | 38,594 | D | F |
| 12 Feb, 2026 | Stephen P. Carey | Common Stock | D | 2,829 | $76.70 | 172,531 | D | F |
| 12 Feb, 2026 | Nikhil Lalwani | Common Stock | D | 11,688 | $76.70 | 368,872 | D | F |
| 12 Feb, 2026 | Ori Gutwerg | Common Stock | D | 1,775 | $76.70 | 77,982 | D | F |
| 12 Feb, 2026 | Christopher Mutz | Common Stock | D | 7,032 | $76.55 | 92,566 | D | S |
| 12 Feb, 2026 | Christopher Mutz | Common Stock | D | 3,173 | $76.70 | 99,598 | D | F |
| 12 Feb, 2026 | Chad Gassert | Common Stock | D | 1,608 | $76.70 | 67,738 | D | F |
| 12 Feb, 2026 | Meredith Cook | Common Stock | D | 1,534 | $76.70 | 69,829 | D | F |
| 12 Feb, 2026 | Krista Davis | Common Stock | D | 1,180 | $76.70 | 54,367 | D | F |
| 11 Feb, 2026 | Thomas Andrew Rowland | Common Stock | D | 1,762 | $76.25 | 39,160 | D | F |
| 11 Feb, 2026 | Stephen P. Carey | Common Stock | D | 5,503 | $76.25 | 175,360 | D | F |